M P Ball

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi A program for treating olanzapine-related weight gain
    M P Ball
    Maryland Psychiatric Research Center at the University of Maryland School of Medicine, Baltimore 21228, USA
    Psychiatr Serv 52:967-9. 2001
  2. ncbi Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine
    M Patricia Ball
    Maryland Psychiatric Research Center, University of Maryland School of Medicine, Catonsville, MD 21228, USA
    Clin Schizophr Relat Psychoses 5:17-25. 2011
  3. ncbi Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia
    E Weiner
    Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland at Baltimore, P O Box 21247, Baltimore, MD 21228, USA
    Am J Psychiatry 158:635-7. 2001
  4. ncbi Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study
    D L Kelly
    Maryland Psychiatric Research Center, University of Maryland, Baltimore, MD, USA
    J Psychopharmacol 23:436-41. 2009

Detail Information

Publications4

  1. ncbi A program for treating olanzapine-related weight gain
    M P Ball
    Maryland Psychiatric Research Center at the University of Maryland School of Medicine, Baltimore 21228, USA
    Psychiatr Serv 52:967-9. 2001
    ..Only the men experienced significant weight loss. No correlation was found between weight loss and exercise or change in psychiatric symptoms...
  2. ncbi Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine
    M Patricia Ball
    Maryland Psychiatric Research Center, University of Maryland School of Medicine, Catonsville, MD 21228, USA
    Clin Schizophr Relat Psychoses 5:17-25. 2011
    ..Therefore, we examined whether atomoxetine may be of benefit for those who have gained weight on either clozapine or olanzapine...
  3. ncbi Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia
    E Weiner
    Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland at Baltimore, P O Box 21247, Baltimore, MD 21228, USA
    Am J Psychiatry 158:635-7. 2001
    ..The study examined the efficacy, tolerability, and safety of supportive group psychotherapy and adjunctive sustained-release bupropion for nicotine addiction in patients with schizophrenia...
  4. ncbi Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study
    D L Kelly
    Maryland Psychiatric Research Center, University of Maryland, Baltimore, MD, USA
    J Psychopharmacol 23:436-41. 2009
    ..Future studies should aim to relate remission criteria to functional outcomes, cognition, and other important symptom domains...